Leveraging Saliva for Insights into Head and Neck Cancer
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252413514 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Saad Rashid und 6 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Program, Mercyhealth Graduate Medical Education Consortium, Rockford, IL 61114, USA. Hauptthemen laut MEDLINE: Saliva, Head and Neck Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Winship Invest$ Team Science Award and the Winship Invest$ Pilot Award.
Abstract (Originalsprache)
Head and neck cancer (HNC) represents a heterogeneous group of malignancies with increasing global incidence and notable mortality. Early detection is essential for improving survival rates and minimizing recurrence; however, existing diagnostic methods are often invasive and complex. There is a need for noninvasive and more effective approaches for early detection and real-time monitoring of HNC. Saliva contains various biomolecules that may serve as indicators of HNC. As a result, saliva-based biomarkers have emerged as a transformative approach in the diagnosis and treatment of HNC due to their ease of collection, non-invasiveness, and potential to provide details about biomolecular changes associated with cancer progression. This narrative review synthesizes the current literature on the potential of saliva as a noninvasive diagnostic tool for HNC. It highlights various biomarkers found in saliva, including cell-free DNA, RNA, proteins, and metabolites, and explores emerging technologies in saliva detection that could transform the future of HNC management. Continued research efforts and larger-scale validation studies are essential to fully realize the potential of saliva-based biopsy and help pinpoint notable biomarkers to improve patient outcomes and reduce mortality associated with HNC worldwide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Internal Medicine Program, Mercyhealth Graduate Medical Education Consortium, Rockford, IL 61114, USA.
- Medical Education, University of Michigan Medical School, Ann Arbor, MI 48105, USA.
- Hematology-Oncology, Advocate Lutheran General Hospital, Park Ridge, IL 60068, USA.
- Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.
- Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Emory University, Atlanta, GA 30322, USA.
ORCID-Profile: Saad Rashid, Saagar Pamulapati, Jianqiang Yang, Nabil F Saba, Yong Teng
Förderung
- NCI NIH HHS
- Winship Invest$ Team Science Award and the Winship Invest$ Pilot Award
Zitieren
APA
Rashid, S., Puttagunta, P., Pamulapati, S., Yang, J., Pocha, S., Saba, N. F., & Teng, Y. (2024). Leveraging Saliva for Insights into Head and Neck Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413514
Vancouver
Rashid S, Puttagunta P, Pamulapati S, Yang J, Pocha S, Saba NF, et al. Leveraging Saliva for Insights into Head and Neck Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413514
BibTeX
@article{Rashid2024,
author = {Rashid, Saad and Puttagunta, Prashant and Pamulapati, Saagar and Yang, Jianqiang and Pocha, Suneha and Saba, Nabil F and Teng, Yong},
title = {Leveraging Saliva for Insights into Head and Neck Cancer},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252413514}
}
EUVIMED